先天性血友病A或B患者重大骨科手术后静脉血栓栓塞发生率及血栓预防措施使用情况:一项系统综述
该系统综述纳入26项观察性研究、1181例血友病A或B患者的关节置换术,总体静脉血栓栓塞事件17例(1.4%;95%CI,0.9%-2.3%),其中术后筛查检出的151例手术中10例(6.6%),未筛查的1080例手术中7例(0.7%)。术后药物血栓预防仅用于15例(1.3%)手术,29.0%的分析人群该信息不可得。结论认为尽管血栓预防使用率低,症状性静脉血栓栓塞发生率似乎较低,并强调需更好地报告血栓结局。
要点
- 血友病患者关节置换术后症状性静脉血栓栓塞发生率低。
- 术后药物血栓预防使用率仅1.3%。
- 需更好地报告血友病患者的血栓结局。
核心结论
- 尽管血友病患者血栓预防使用率低,关节置换术后症状性静脉血栓栓塞发生率似乎较低。
- 强调需要更好地报告血友病患者的血栓结局,以应对血友病领域持续的变化。
研究设计与样本
- 系统综述,系统筛选4个在线生物医学数据库,纳入26项观察性研究,报告1181例血友病A或B患者的关节置换术。
- 排除病例报告和少于10例患者的病例系列。
主要发现
- 总体报告17例静脉血栓栓塞事件(1.4%;95%CI,0.9%-2.3%)。
- 术后筛查检出的151例手术中报告10例(6.6%)静脉血栓栓塞事件。
- 未进行术后筛查的1080例手术中报告7例(0.7%)静脉血栓栓塞事件。
- 21项研究明确了血栓预防方案;术后血栓预防用于15例(1.3%)手术。
- 29.0%的分析人群血栓预防信息不可得。
关键数值与推荐
- 8项研究以静脉血栓栓塞发生率为主要结局。
- 5项研究报告筛查检出的静脉血栓栓塞,21项报告症状性静脉血栓栓塞事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) is a well-recognized complication after total joint replacement (TJR). Persons with hemophilia A or B are considered at low postoperative VTE risk due to their coagulation factor deficiencies, and administering pharmacologic thromboprophylaxis is often considered contraindicated. However, using factor replacement therapy could increase the postoperative VTE risk. OBJECTIVES: To analyze best available evidences of VTE rates in persons with hemophilia A or B undergoing lower limb TJR and the use of postoperative pharmacologic thromboprophylaxis. METHODS: We systematically screened 4 online biomedical databases to identify studies reporting VTE rates in patients with hemophilia after TJR. Case reports and case series with less than 10 patients were excluded. RESULTS: Twenty-six observational studies were included in this systematic review, reporting 1181 TJRs in patients with hemophilia A or B. Eight studies had VTE rates as the primary outcome. Five studies reported screen-detected VTE, while 21 reported symptomatic VTE events. Overall, 17 VTE events were reported (1.4%; 95% CI, 0.9%-2.3%), including 10 (6.6%) after 151 surgeries with postoperative VTE screening and 7 (0.7%) after 1080 surgeries without postoperative screening. Thromboprophylaxis protocols were specified in 21 studies; postoperative thromboprophylaxis was used in 15 (1.3%) surgeries. This information was not available for 29.0% of the analyzed population. CONCLUSION: Despite the low thromboprophylaxis use in patients with hemophilia, rates of symptomatic VTE after TJR appeared to be low. We also highlighted the need to better report the thrombotic outcome in persons with hemophilia to face the ongoing changes in the hemophilia landscape.
引用
- Santagata D, Abenante A, Squizzato A, et al. Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review. J Thromb Haemost. 2024. PMID: 38215910. doi:10.1016/j.jtha.2023.12.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。